Business Notes: Westfield Acquired by French Shopping Center Company

Plus: Marriott plans to open 40 luxury hotels next year; United Therapeutics testing genetically targeted drugs


Westfield logo

Westfield malls acquired by French company

The French shopping center company Unibail-Rodamco agreed this week to purchase Westfield Corp., the Australian company that owns dozens of malls in the United States and Europe, including Westfield Montgomery mall in Bethesda and Westfield Wheaton, for $15.7 billion.

The deal was seen by commercial real estate analysts as a way for the shopping center operators to buttress and consolidate their business against the threat of online retail competition, according to The Financial Times. With Westfield’s mall portfolio, Unibail will now own 104 shopping centers in 13 countries.

Westfield has invested significantly in its properties in recent years as shoppers have left many suburban malls behind. At Westfield Montgomery, for example, the company spent $90 million to construct the “dining terrace” addition to the Bethesda mall. The 40,000-square-foot expansion is home to about a dozen restaurants and the ArcLight Cinemas movie theater.

Marriott plans to open 40 luxury hotels in 2018

Marriott has ambitious plans next year as it works to attract affluent travelers. The Bethesda-based hotel company announced this week it aims to open 40 new luxury hotels in 2018. Hotel brands Marriott plans to expand include The Ritz-Carlton, Ritz-Carlton Reserve, St. Regis, W Hotels and The Luxury Collection.

The 40 new luxury hotels are a portion of the 200 new hotels Marriott expects to open next year.

“We see luxury as a launch pad for self-actualization, with bucket lists evolving from where you want to go to who you can be,” Tina Edmundson, the global brand officer for Marriott, said. “With data showing a global shift in perception around luxury, we are uniquely positioned to provide personalized and truly differentiated experiences that resonate with this next-generation jetsetter.”

United Therapeutics is testing genetically targeted drugs

Silver Spring-based United Therapeutics, which has been developing a process to grow human organs, is now working on ways to determine if it can use genetic testing to identify which people will most benefit from its drugs.

Martine Rothblatt, the company’s CEO, told business leaders at a Leadership Greater Washington event earlier this month that she wants United Therapeutics to master the technology known as pharmacogenomics, according to The Washington Business Journal.

To do so, the company has been sequencing the genomes of clinical trial participants, so it can later analyze if genetic factors might have made a drug more or less effective for a particular patient. Rothblatt said the analysis could help reduce costs of the Federal Drug Administration’s approval process for new drugs by being able to accurately demonstrate which patients stand to benefit from a new drug by using the genetic analysis.

Back to Bethesda Beat

Edit Module
Edit ModuleShow Tags

Archive »Related Articles

Update: MCPS Closing on Wednesday, Instead of Delay

Out of concern for road conditions

Superintendent: MCPS Must Live ‘Closer to the Margins’ To Meet Leggett’s Savings Target

Council members set to discuss plan to reduce school system spending by $25 million

School Board Comes Out in Opposition to Bus Inspection Bill

MCPS staff says the measure could force buses to pull over at weigh stations, stop for roadside checks

Police Blotter: Three Vehicles Stolen; House Burglaries in Potomac and Silver Spring

Crimes reported to Montgomery County and Rockville police Dec. 13-19
Edit ModuleShow Tags Edit Module
Edit Module
Edit ModuleShow Tags Edit ModuleShow Tags

More »

Beautiful Georgian Colonial

Potomac, $1,748,800

California Contemporary

Bethesda, $1,150,000

New Construction

Bethesda, $1,299,999

Brand New + Great Location

Bethesda, $1,369,000

2 Private Acres

Potomac, $1,795,000
Edit Module


Your Guides to Leading
Local Professionals

Edit Module
Edit ModuleShow Tags Edit Module

Edit Module